Login to Your Account

ViroPharma’s Picovir Goes Before FDA Panel; Analysts Divided

By Kim Coghill

Tuesday, March 19, 2002
WASHINGTON In recent days, ViroPharma Inc. has been the subject of speculation surrounding the outcome of today’s government panel hearing on whether to recommend Picovir as a treatment for the common cold. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription